Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 3/2018

01-03-2018 | Review

Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients

Authors: Maha AT Elsebaie, Zeinab Elsayed

Published in: Archives of Gynecology and Obstetrics | Issue 3/2018

Login to get access

Abstract

Purpose

Recently, conservative approaches such as wide local excisions and neoadjuvant chemotherapy are being considered to select young adult females with gynecologic RMS who have strong desire to preserve fertility. This analysis aims to identify prognosticators affecting survival outcomes and defining potential candidacy for fertility-preservation. Another focus is to explore the role of chemotherapy in reducing the need for aggressive surgery and the role of radiotherapy in decreasing rates of local failure.

Methods

A comprehensive database search identified 137 females > 16 years old with primary non-metastatic gynecologic RMS, who were included in a multivariate survival analysis.

Results

5-year overall survival rate was 65%. Patients < 50 years old, with cervix uteri primaries, well-defined/polypoid presentations, embryonal histology and superficial tumors were more likely to survive. Deeply invasive disease and alveolar/pleomorphic histology significantly increased risks of treatment failure and tumor recurrence. Chemotherapy use was a significant multivariate predictor of better overall and metastasis-free survival. Radical surgery did not add local control or overall survival benefit for patients with superficial lesions (minimal/no cervical stromal invasion and no myometrial invasion).

Conclusions

While high-quality clinical trial evidence is missing, existing evidence seems to support holding back on radical surgery for selected candidates with well-defined, polypoid, superficial, embryonal cervical/endometrial RMS lesions that could be completely excised with conservative surgery; further local resections with/without radiotherapy are then warranted based on margin status. Experience on the use of neoadjuvant chemotherapy in the conservative management of uterine RMS in adults is very limited, though this approach is golden-standard in pediatrics. A suggested scheme is introduced for the management of uterine RMS.
Appendix
Available only for authorised users
Literature
1.
Arndt CA, Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP et al (2001) What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 91(12):2454–2468CrossRefPubMed
2.
Miettinen M, Wahlstrom T, Vesterinen E, Saksela E (1983) Vaginal polyps with pseudosarcomatous features. A clinicopathologic study of seven cases. Cancer 51(6):1148–1151CrossRefPubMed
3.
Kirsch CH, Goodman M, Esiashvili N (2014) Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006. Am J Clin Oncol 37(1):47–50CrossRefPubMed
4.
Copeland LJ, Gershenson DM, Saul PB, Sneige N, Stringer CA, Edwards CL (1985) Sarcoma botryoides of the female genital tract. Obstet Gynecol 66(2):262–266PubMed
5.
Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L et al (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98(3):571–580CrossRefPubMed
6.
Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2600 patients. J Clin Oncol 27(20):3391–3397CrossRefPubMed
7.
Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M et al (2005) Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol 97(1):90–95CrossRefPubMed
8.
Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL (2005) Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 23(28):7143–7151CrossRefPubMed
9.
Narin MA, Karalok A, Basaran D, Turkmen O, Turan T, Tulunay G (2016) Embryonal rhabdomyosarcoma of the cervix in young women. J Adolesc Young Adult Oncol 5:261–266CrossRefPubMed
10.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341CrossRef
11.
Plante M (2013) Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy. Int J Gynecol Cancer 23(6):982–989CrossRefPubMed
12.
Laurelli G, Falcone F, Scaffa C, Messalli EM, Del Giudice M, Losito S et al (2015) Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature. Eur J Obstet Gynecol Reprod Biol 195:61–66CrossRefPubMed
13.
Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat 53:457–481CrossRef
14.
Altman DG (1990) Practical statistics for medical research. CRC Press, Boca Raton
15.
Zanetta G, Rota S, Lissoni A, Chiari S, Bratina G, Mangioni C (1999) Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females. Br J Cancer 80(3–4):403–406CrossRefPubMedPubMedCentral
16.
Lin J, Lam SK, Cheung TH (1995) Sarcoma botryoides of the cervix treated with limited surgery and chemotherapy to preserve fertility. Gynecol Oncol 58(2):270–273CrossRefPubMed
17.
Montag TW, D’ablaing G, Schlaerth JB, Gaddis OJ, Morrow CP (1986) Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol 25:171–194CrossRefPubMed
18.
Zeisler H, Mayerhofer K, Joura EA, Bancher-Todesca D, Kainz C, Breitenecker G et al (1998) Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 69(1):78–83CrossRefPubMed
19.
Scaravilli G, Simeone S, Dell’Aversana Orabona G, Capuano S, Serao M, Rossi R et al (2009) Case report of a sarcoma botryoides of the uterine cervix in fertile age and literature review. Arch Gynecol Obstet 280(5):863–866CrossRefPubMed
20.
Hertel H, Kohler C, Grund D, Hillemanns P, Possover M, Michels W et al (2006) Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol 103(2):506–511CrossRefPubMed
21.
Karaman E, Akbayir O, Kocaturk Y, Cekic S, Filiz FB, Gulkilik A (2011) Successful treatment of a very rare case: locally treated cervical rhabdomyosarcoma. Arch Gynecol Obstet 284:1019–1022CrossRefPubMed
22.
Gordon AN, Montag TW (1990) Sarcoma botryoides of the cervix: excision followed by adjuvant chemotherapy for preservation of reproductive function. Gynecol Oncol 36(1):119–124CrossRefPubMed
23.
Bernal KL, Fahmy L, Remmenga S, Bridge J, Baker J (2004) Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol 95(1):243–246CrossRefPubMed
24.
Hays DM, Shimada H, Raney RBJ, Tefft M, Newton W, Crist WM et al (1988) Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer 61:1893–1903CrossRefPubMed
25.
Brand E, Berek JS, Nieberg RK, Hacker NF (1987) Rhabdomyosarcoma of the uterine cervic. Sarcoma botryoides. Cancer 60(7):1552–1560CrossRefPubMed
26.
Leuschner I, Harms D, Mattke A, Koscielniak E, Treuner J (2001) Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 25(7):856–864CrossRefPubMed
27.
Corpron CA, Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W et al (1995) Conservative management of uterine pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot. J Pediatr Surg 30(7):942–944CrossRefPubMed
28.
Martelli H, Oberlin O, Rey A, Godzinski J, Spicer RD, Bouvet N et al (1999) Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology. J Clin Oncol 17(7):2117–2122CrossRefPubMed
29.
Daya DA, Scully RE (1988) Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol 29:290–304CrossRefPubMed
30.
Kriseman ML, Wang WL, Sullinger J, Schmeler KM, Ramirez PT, Herzog CE et al (2012) Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol 126(3):351–356CrossRefPubMedPubMedCentral
31.
Dehner LP, Jarzembowski JA, Hill DA (2012) Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol 25(4):602–614CrossRefPubMed
32.
Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB et al (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification–an Intergroup Rhabdomyosarcoma Study. Cancer 76(6):1073–1085CrossRefPubMed
33.
Perrone T, Carson LF, Dehner LP (1990) Rhabdomyosarcoma with heterologous cartilage of the uterine cervix: a clinicopathologic and immunohistochemical study of an aggressive neoplasm in a young female. Med Pediatr Oncol 18(1):72–76CrossRefPubMed
34.
La Starza R, Nofrini V, Pierini T, Pierini V, Zin A, Bisogno G et al (2015) Molecular cytogenetics detect an unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 fusion in rhabdomyosarcoma with mixed embryonal/alveolar features. Pediatr Blood Cancer 62(12):2238–2241CrossRefPubMed
35.
Treetipsatit J, Kittikowit W, Zielenska M, Chaipipat M, Thorner PS, Shuangshoti S (2009) Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review. Pediatr Dev Pathol 12(5):383–389CrossRefPubMed
36.
Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC et al (2009) Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging–initial experience. Radiology 250(3):784–792CrossRefPubMed
37.
Beddy P, Moyle P, Kataoka M, Yamamoto AK, Joubert I, Lomas D et al (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262(2):530–537CrossRefPubMed
38.
Lakhman Y, Akin O, Park KJ, Sarasohn DM, Zheng J, Goldman DA et al (2013) Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology 269(1):149–158CrossRefPubMed
39.
Kim SH, Choi BI, Han JK, Kim HD, Lee HP, Kang SB et al (1993) Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 17(4):633–640CrossRefPubMed
40.
Sironi S, De Cobelli F, Scarfone G, Colombo E, Bolis G, Ferrari A et al (1993) Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness. Radiology 188(3):797–801CrossRefPubMed
41.
Kayton ML, Wexler LH, Lewin SN, Park KJ, La Quaglia MP, Abu-Rustum NR (2009) Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy. J Pediatr Surg 44(4):862–867CrossRefPubMedPubMedCentral
42.
Osmanaǧaoǧlu MA, Osmanaǧaoǧlu S, Çobanoǧlu Ü, Bozkaya H (2005) Embryonal rhabdomyosarcoma of the cervix: a case report. Geburtshilfe Frauenheilkd 65(2):195–198CrossRef
43.
Abdeljalil K, Asma B, Kouira M, Faten H, Sawssen M, Samir H et al (2014) Embryonal rhabdomyosarcoma of the uterine cervix: two cases report and literature review. Open J Obstet Gynecol 4(14):868CrossRef
44.
Hahlin M, Jaworski RC, Wain GV, Harnett PR, Neesham D, Bull C (1998) Integrated multimodality therapy for embryonal rhabdomyosarcoma of the lower genital tract in postpubertal females. Gynecol Oncol 70(1):141–146CrossRefPubMed
45.
Walterhouse DO, Meza JL, Breneman JC, Donaldson SS, Hayes-Jordan A, Pappo AS et al (2011) Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children’s Oncology Group. Pediatr Blood Cancer 57(1):76–83CrossRefPubMedPubMedCentral
46.
Borka K, Patai K, Rendek A, Sobel G, Paulin F (2006) Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal patient. Pathol Oncol Res 12(2):102–104CrossRefPubMed
47.
Ordi J, Stamatakos MD, Tavassoli FA (1997) Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 16(4):369–377CrossRefPubMed
48.
Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19(12):3091–3102CrossRefPubMed
49.
Podczaski E, Sees J, Kaminski P, Sorosky J, Larson JE, DeGeest K et al (1990) Rhabdomyosarcoma of the uterus in a postmenopausal patient. Gynecol Oncol 37(3):439–442CrossRefPubMed
50.
51.
Fadare O, Bonvicino A, Martel M, Renshaw IL, Azodi M, Parkash V (2010) Pleomorphic rhabdomyosarcoma of the uterine corpus: a clinicopathologic study of 4 cases and a review of the literature. Int J Gynecol Pathol 29(2):122–134CrossRefPubMed
52.
Ditto A, Martinelli F, Carcangiu M, Solima E, de Carrillo KJ, Sanfilippo R et al (2013) Embryonal rhabdomyosarcoma of the uterine cervix in adults: a case report and literature review. J Low Genit Tract Dis 17(4):e12–e17CrossRefPubMed
53.
Ogilvie CM, Crawford EA, Slotcavage RL, King JJ, Lackman RD, Hartner L et al (2010) Treatment of adult rhabdomyosarcoma. Am J Clin Oncol 33(2):128–131PubMed
54.
Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN et al (2009) Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803. J Clin Oncol 27(31):5182–5188CrossRefPubMedPubMedCentral
55.
Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W, Lobe TE et al (1995) Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III. Journal of pediatric surgery 30(7):1034–1036 (discussion 6–7) CrossRefPubMed
56.
Andrassy RJ, Wiener ES, Raney RB, Hays DM, Arndt CA, Lobe TE et al (1999) Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediat Surg 34(5):731–734 (discussion 4-5) CrossRefPubMed
57.
Smeele LE, Kostense PJ, van der Waal I, Snow GB (1997) Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 15(1):363–367CrossRefPubMed
Metadata
Title
Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients
Authors
Maha AT Elsebaie
Zeinab Elsayed
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4591-6

Other articles of this Issue 3/2018

Archives of Gynecology and Obstetrics 3/2018 Go to the issue

Maternal-Fetal Medicine

Effects of dietary advice on insulin-like growth factors among healthy newborns

Correspondence

Letter to the Editor: Comment on “Contemporary epidemiology and novel predictors of uterine rupture: a nationwide population-based study”

General Gynecology

Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial

Maternal-Fetal Medicine

Bedside risk estimation of morbidly adherent placenta using simple calculator

Gynecologic Endocrinology and Reproductive Medicine

Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study

General Gynecology

Does she have adnexal torsion? Prediction of adnexal torsion in reproductive age women